Novel treatment for post-herpetic neuralgia.

  • Published 2014 in Nursing older people

Abstract

Neuropathic pain, including post-herpetic neuralgia after shingles, is not well controlled by existing treatments. EMA401 is an angiotensin II type 2 receptor antagonist developed in the search for antihypertensive drugs. The renin-angiotensin system has roles outside the cardiovascular system, including in the central and peripheral nervous systems. 
DOI: 10.7748/nop.26.7.13.s18

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.